vs
Side-by-side financial comparison of GLAUKOS Corp (GKOS) and MAXLINEAR, INC (MXL). Click either name above to swap in a different company.
GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $137.2M, roughly 1.1× MAXLINEAR, INC). GLAUKOS Corp runs the higher net margin — 6.2% vs -32.9%, a 39.1% gap on every dollar of revenue. On growth, MAXLINEAR, INC posted the faster year-over-year revenue change (43.0% vs 41.2%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 22.1%).
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
MaxLinear, Inc. is an American electronic hardware company. Founded in 2003, it provides highly integrated radio-frequency (RF) analog and mixed-signal semiconductor products for broadband communications applications. It is a New York Stock Exchange-traded company.
GKOS vs MXL — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $150.6M | $137.2M |
| Net Profit | $9.4M | $-45.1M |
| Gross Margin | 77.9% | 57.5% |
| Operating Margin | 9.0% | 30.0% |
| Net Margin | 6.2% | -32.9% |
| Revenue YoY | 41.2% | 43.0% |
| Net Profit YoY | — | -203.0% |
| EPS (diluted) | — | $-0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $150.6M | $137.2M | ||
| Q4 25 | $143.1M | $136.4M | ||
| Q3 25 | $133.5M | $126.5M | ||
| Q2 25 | $124.1M | $108.8M | ||
| Q1 25 | $106.7M | $95.9M | ||
| Q4 24 | $105.5M | $92.2M | ||
| Q3 24 | $96.7M | $81.1M | ||
| Q2 24 | $95.7M | $92.0M |
| Q1 26 | $9.4M | $-45.1M | ||
| Q4 25 | $-133.7M | $-14.9M | ||
| Q3 25 | $-16.2M | $-45.5M | ||
| Q2 25 | $-19.7M | $-26.6M | ||
| Q1 25 | $-18.1M | $-49.7M | ||
| Q4 24 | $-33.6M | $-57.8M | ||
| Q3 24 | $-21.4M | $-75.8M | ||
| Q2 24 | $-50.5M | $-39.3M |
| Q1 26 | 77.9% | 57.5% | ||
| Q4 25 | -1.1% | 57.6% | ||
| Q3 25 | 78.4% | 56.9% | ||
| Q2 25 | 78.3% | 56.5% | ||
| Q1 25 | 77.2% | 56.1% | ||
| Q4 24 | 72.9% | 55.6% | ||
| Q3 24 | 76.6% | 54.4% | ||
| Q2 24 | 76.4% | 54.6% |
| Q1 26 | 9.0% | 30.0% | ||
| Q4 25 | -97.7% | -10.9% | ||
| Q3 25 | -12.3% | -32.7% | ||
| Q2 25 | -18.3% | -22.6% | ||
| Q1 25 | -19.4% | -48.0% | ||
| Q4 24 | -27.2% | -44.7% | ||
| Q3 24 | -25.5% | -82.3% | ||
| Q2 24 | -31.3% | -44.4% |
| Q1 26 | 6.2% | -32.9% | ||
| Q4 25 | -93.4% | -10.9% | ||
| Q3 25 | -12.2% | -36.0% | ||
| Q2 25 | -15.8% | -24.4% | ||
| Q1 25 | -17.0% | -51.8% | ||
| Q4 24 | -31.8% | -62.8% | ||
| Q3 24 | -22.1% | -93.4% | ||
| Q2 24 | -52.8% | -42.7% |
| Q1 26 | — | $-0.52 | ||
| Q4 25 | $-2.34 | $-0.17 | ||
| Q3 25 | $-0.28 | $-0.52 | ||
| Q2 25 | $-0.34 | $-0.31 | ||
| Q1 25 | $-0.32 | $-0.58 | ||
| Q4 24 | $-0.56 | $-0.68 | ||
| Q3 24 | $-0.39 | $-0.90 | ||
| Q2 24 | $-1.00 | $-0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $276.7M | $61.1M |
| Total DebtLower is stronger | — | $123.8M |
| Stockholders' EquityBook value | $670.9M | $454.2M |
| Total Assets | $893.3M | $771.3M |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $276.7M | $61.1M | ||
| Q4 25 | $90.8M | $72.8M | ||
| Q3 25 | $98.2M | $111.9M | ||
| Q2 25 | $100.8M | $108.6M | ||
| Q1 25 | $114.3M | $102.8M | ||
| Q4 24 | $169.6M | $118.6M | ||
| Q3 24 | $100.1M | $148.5M | ||
| Q2 24 | $68.1M | $185.1M |
| Q1 26 | — | $123.8M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $670.9M | $454.2M | ||
| Q4 25 | $656.2M | $451.9M | ||
| Q3 25 | $769.5M | $464.7M | ||
| Q2 25 | $765.1M | $488.3M | ||
| Q1 25 | $764.0M | $493.2M | ||
| Q4 24 | $766.9M | $516.3M | ||
| Q3 24 | $668.5M | $556.9M | ||
| Q2 24 | $665.2M | $617.3M |
| Q1 26 | $893.3M | $771.3M | ||
| Q4 25 | $893.5M | $796.4M | ||
| Q3 25 | $999.4M | $808.1M | ||
| Q2 25 | $987.0M | $863.7M | ||
| Q1 25 | $966.2M | $855.3M | ||
| Q4 24 | $974.8M | $864.6M | ||
| Q3 24 | $926.5M | $895.3M | ||
| Q2 24 | $919.7M | $973.2M |
| Q1 26 | — | 0.27× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
